Showing 11-20 of 7110 results for "".
Fertility Medications and Chronic Spontaneous Urticaria
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/fertility-medications-and-chronic-spontaneous-urticaria/50955/Michelle Tarbox, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the implications of her International Journal of Dermatology article “Fertility Medications and Urticaria Suptypes: Real-World Comparative Study Analyzing Risks Among Clomiphene, GnRH AgonisRonald B. Prussick, MD, FRCPC
https://practicaldermatology.com/topics/general-topics/ronald-b-prussick-md-frcpc/21299/Antioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.Physician Spotlight: Haley B. Naik, MD, MHSc
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-haley-b-naik-md-mhsc/23518/ILUMYA SUPPORT™ patient access for commercial and Medicare Part B patients
https://practicaldermatology.com/topics/psoriasis/ilumya-support-patient-access-for-commercial-and-medicare-part-b-patients/19860/ILUMYA SUPPORT™ offers comprehensive programs and services to help patients start and stay on therapy with ILUMYA™. Learn about the three main patient access programs offered by ILUMYA SUPPORT™: the Early Access Program, the Co-pay Program, and the Patient Assistance Program. ILUMYA™ is reimbursed uSocial Media as a Force for Good: How to Think Like a B Corp
https://practicaldermatology.com/topics/practice-management/social-media-as-a-force-for-good-how-to-think-like-a-b-corp/24009/For dermatologists, social media networks are underutilized when marketing their practices—create quality and trusted material, deliver practice-specific messaging strategies, and convey and sustain reliable information.DermWireTV: Cassiopeia Winlevi; Psoriasis Guidelines; Cyndi Lauper's PsO in the Know; Sarah Michelle Gellar's CoolSculpting
https://practicaldermatology.com/topics/psoriasis/dermwiretv-cassiopeia-winlevi-psoriasis-guidelines-cyndi-laupers-pso-in-the-know-sarah-michelle-gellars-coolsculpting/19852/The FDA has approved Winlevi (Clascoterone cream 1%) from Cassiopea for the treatment of acne in patients 12 years and older.New Guidelines of care for the Management of Psoriasis with Systemic Nonbiologic Therapies, jointly issued by the American Academy of Dermatology and the National Psoriasis FoThe Latest in Blistering Diseases
https://practicaldermatology.com/programs/practical-dermatology/the-latest-in-blistering-diseases/33007/Kim B. Yancey, MD, a professor of dermatology at UT Southwestern Medical Center in Dallas, talks about current treatments and techniques for blistering diseases, focusing specifically autoimmune blistering diseases.Fillers and Cosmetic Procedures
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/fillers-and-cosmetic-procedures/19367/Hayes B. Gladstone, MD discusses emerging options in the field of cosmetic dermatology, including new devices and injectables.Taylor Made: One-of-a-kind Solutions for Device-based Services
https://practicaldermatology.com/topics/practice-management/taylor-made-one-of-a-kind-solutions-for-device-based-services/18789/An expert on the leading edge of device-based interventions, Mark B. Taylor, MD has learned when and how to adopt technologies and how to get the most from the systems in his practice. In this edition of Best Practices in Aesthetics, host Joel L. Cohen, MD asks Dr. Taylor to share his tips for optim